Biologics Archives

Publication

Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma

Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…

Certara2025 年 8 月 13 日

Publication

Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial

Explore updated results from the Phase 3 TROPiCS-02 trial of Sacituzumab Govitecan in advanced HR+/HER2–…

Certara2025 年 8 月 13 日

Announcement

Certara 宣布发布 25.5 版本，新增动态数据子集功能并提升了分析能力

D360 v25.5 allows scientists to divide up a dataset into series of compounds & perform…

Certara2025 年 8 月 7 日

Press Coverage

药代动力学/药效学研究的建模方法

Explore insights from Certara experts on how PK/PD modeling streamlines biologic drug development.

Certara2025 年 8 月 5 日

Webinar

理解抗体-药物偶联物（ADCs）的药代动力学：从 NCA 到群体药代动力学（PopPK）方法

Certara2025 年 8 月 1 日

Press Coverage

FDA plans to phase out animal testing requirements

Discover how the FDA plans to replace animal testing with AI and organ-on-chip technologies for…

Certara2025 年 4 月 10 日

Publication

Postmarketing Assessment of Antibody–Drug Conjugates: Proof-of-Concept Using Model-Based Meta-Analysis and a Clinical Utility Index Approach

This study explores a model-based meta-analysis (MBMA) and a clinical utility index (CUI) approach to…

Certara2025 年 3 月 4 日

Press Coverage

2025 cell and gene challenges: Scalability, supply chain and manufacturing

Explore insights on 2025 challenges in cell and gene therapy, including commercial viability, with expert…

Certara2025 年 2 月 3 日

Press Coverage

AI in Life Sciences Finds an Early Success and Will Continue in 2025

Fran Brown highlights how AI in life sciences drives more precise drug development and reduces…

Certara2024 年 12 月 24 日

Blog

CMS 细胞与基因治疗（CGT）准入模式详解：你从未听说过的最重要的药品定价立法

2024 年 12 月 13 日 The Centers for Medicare & Medicaid Services (CMS) is piloting a program…

Certara2024 年 12 月 13 日

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software

生物制剂

Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma

Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial

Certara 宣布发布 25.5 版本，新增动态数据子集功能并提升了分析能力

药代动力学/药效学研究的建模方法

理解抗体-药物偶联物（ADCs）的药代动力学：从 NCA 到群体药代动力学（PopPK）方法

FDA plans to phase out animal testing requirements

Postmarketing Assessment of Antibody–Drug Conjugates: Proof-of-Concept Using Model-Based Meta-Analysis and a Clinical Utility Index Approach

2025 cell and gene challenges: Scalability, supply chain and manufacturing

AI in Life Sciences Finds an Early Success and Will Continue in 2025

CMS 细胞与基因治疗（CGT）准入模式详解：你从未听说过的最重要的药品定价立法

订阅时事通讯

快捷链接

解决方案

联系我们